ViiV Healthcare: HIV Combo Therapy Candidate Fails Phase 3
Eli Lilly and Company (LLY) To Cut Up To 100 Indy Jobs, Send Some Work Overseas
Synlogic Secures $29.4 Million Series A Financing Led By Atlas Venture
FDA Grants Genentech (RHHBY)’s Avastin Priority Review For Recurrent Platinum-Resistant Ovarian Cancer
Neogen Corporation (NEOG) Announces Quarterly Earnings Results, Misses Estimates By $0.02 EPS
Agena Biosciences Appoints Peter Dansky As Chief Executive Officer
Avalanche Biotechnologies Boosts IPO As 2 More Biotechs Go Public This Week
Cancer Biotech Loxo Oncology Sets Terms For $57 Million IPO
SAGE Therapeutics Receives Fast Track Designation For Lead Compound SAGE-547 To Treat Status Epilepticus
Cancer Genetics, Inc. (CGIX) Announces Acquisition Of Gentris Corporation, A Leading Global Pharmacogenomics Company, And Increases Contract Backlog To Over $18 Million
Major Restructure At Allergan Inc. (AGN) Amid Valeant Pharmaceuticals International (VRX) Takeover Battle; Allergan Inc. To Cut 1,500 Jobs
Cerecor Inc. Closes On Initial Tranche Of US $32 Million Series B Financing
Phosphagenics Limited (POH.AX) Completes First Tranche of A $19.3 Million Capital Raising
Anacor Pharmaceuticals, Inc. (ANAC) Inks Exclusive Deal With Sandoz, Inc. For Kerydin; Anacor To Receive Upfront $40 Million
StemCells Inc. (STEM) Announces Closing Of $20 Million Offering
Catalent Pharma Solutions Sees IPO Of 42.5 Million Shares Priced Between $19-$22/Share
Arno Therapeutics Appoints Alexander Zukiwski, M.D. As Interim Chief Executive Officer And Mr. Lawrence Kenyon As Chief Operating Officer
Baxter International, Inc. (BAX) Initiates Voluntary Worldwide Recall Of Four Lots Of IV Solutions Due To The Presence Of Particulate Matter
See All News >
//-->